Meet Novalix at the Target to Patient 2026 (T2P26) conference organized by the Society of Medicines Research (SMR) in Hinxton, UK, from April 20 to 21.
This bienual two-day meeting will focus on ground-breaking advances during sessions on drug discovery:
– Machine Learning and Target identification
– Rewiring biology through induced proximity
– Impact of advances in analytical sciences
– Complex in vitro models
– Improving clinical trial outcomes
Meet Sascha Hartmann, Director Business Development, to know more about our services, and to explore how Novalix can support your drug discovery challenges from the earliest stages to candidate selection.
Event
Visit websiteDate
From
Apr 20, 2026
to
Apr 21, 2026
Location
Hinxton, UK
Attendees
Sascha Hartmann
Director Business Development